首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Issue information
Authors:Xiaoyan Wang  Yanli Wang  Jinbo Zhang  Xue Guan  Minggang Chen  Yumei Li  Li Zhang
Institution:1. Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education, People's Republic of China;2. Department of Physiology, Harbin Medical University‐Daqing, Daqing, Heilongjiang Province, People's Republic of China;3. Department of Cardiology, Kailuan General Hospital, Tangshan, Hebei Province, People's Republic of China;4. Department of Pharmacology, Harbin Medical University‐Daqing, Daqing, Heilongjiang Province, China
Abstract:Galectin‐3 (Gal‐3) plays a critical role in vascular inflammation and fibrosis. The role of TGF‐β1 in mediating pulmonary vascular fibrosis is well documented; thus, we suspected that Gal‐3 could be an important factor in TGF‐β1‐induced fibrosis in pulmonary adventitial fibroblasts (PAFs). We treated rats with monocrotaline (MCT) and cultured PAFs with TGF‐β1 to stimulate fibrosis. We found that MCT injection induced vessel thickening and extracellular matrix deposition in vivo. TGF‐β1 stimulated the production of collagen and fibronectin (Fn) protein in vitro. TGF‐β1 promoted the expression of Gal‐3 and its translocation, while silencing Gal‐3 reduced Col‐1a deposition. Blockage of STAT3 decreased the expression of Gal‐3 induced by TGF‐β1. Gal‐3 increased Col‐1a accumulation and downregulated matrix metallopeptidase 9 (MMP‐9) expression in PAFs, but it did not affect Fn expression. These findings demonstrate that Gal‐3 is required for TGF‐β1‐stimulated vascular fibrosis via a STAT3 signaling cascade and that MMP‐9 is also involved in TGF‐β1/Gal‐3‐induced vascular fibrosis.
Keywords:fibrosis  Galectin‐3  pulmonary adventitial fibroblasts  TGF‐β1
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号